Laura Zeller/LinkedIn and Menno Germans/LinkedIn
Dec 20, 2025, 07:41
Specific Reversal Agents for Direct Oral Anticoagulants in Neurosurgical Emergencies
RPTH Journal shared a post on LinkedIn:
“In emergency neurosurgery, rapid DOAC reversal is critical. This systematic review evaluates perioperative outcomes of idarucizumab and andexanet alfa, highlighting evidence gaps and safety insights.
If you work in hemostasis, neurosurgery, or acute care, this one’s worth a look.
Senior Author: Menno Germans”
Title: Specific reversal agents for direct oral anticoagulants in neurosurgical emergencies – a systematic review
Authors: Laura Zeller, Jonas Rohr, Giovanna Brandi, Christoph Globas, Alexander Kaserer, Matthias Greutmann, Tilman Schubert, Jan-Dirk Studt, Katharina Geiling, Luca Regli, Menno R. Germans
Never miss hematology news with Hemostasis Today.
-
May 24, 2026, 04:57Ahmed Elsobky: Strengthening Hemophilia Care Under Egypt’s Universal Health Insurance System
-
May 24, 2026, 04:49Hussien Hishmat: There Is More to Pulmonary Embolism than Just Anticoagulation
-
May 24, 2026, 04:25Sarah Elkourashy: Diagnostic Challenges and Management Strategies for Maternal–Fetal Outcomes in TTP
-
May 24, 2026, 04:11Ayah Ghazi Al-Qasrawi: How Should Sepsis-Induced DIC Be Managed in Patients Receiving Thienopyridines
-
May 24, 2026, 04:05Kate Hayward: Recent Stroke Recovery and Rehabilitation Highlights
-
May 24, 2026, 03:33Raghavendra Rao: Short-Term Outcomes of Combined EVLA and Foam Sclerotherapy
-
May 24, 2026, 03:33Lucia Mazzolai: Systemic Vascular Approach to Peripheral Artery Disease
-
May 24, 2026, 03:32Isaac Okello: Africa CDC Launches Continental Framework for Sickle Cell Disease
-
May 24, 2026, 03:32Karine Kocharian: Advancing Hemophilia Care Equity at the 79th World Health Assembly